RECORDED PRESENTATIONS New presentations will be released every week leading up to our live panel discussions on April 15/16. NEW THIS WEEK Therapy of Type 1 Diabetes: The DCCT-EDIC Trials David M. Nathan, MD The Present and Future of Pancreas and Islet Transplantation James Shapiro Immune-based Therapies for Type 1 Diabetes Matthias von Herrath Therapeutic Approaches to Circumventing Autoimmunity Kevan Herold, MD THANKS TO OUR SPONSORS Foundation Platinum Sapphire Diamond Gold " Past Insulin 100 Presentations Evolving Technologies for the Management of Diabetes and Pregnancy Denice Feig, MD Insights from the T1D Exchange Experience David Maahs, MD, PhD Novel Strategies for Defeating Islet Autoimmunity Pere Santamaria Islet Inflammation and Type 1 Diabetes – New Perspectives Decio L. Eizirik, MD, PhD The Bleeding Edge: Open Source Algorithms, Research & What’s Next in Do-It-Yourself Artificial Pancreas Systems Dana Lewis Load More New Closed Loop Insulin Systems Roman Hovorka, PhD Read the Abstract Whither the Future of Insulin Management in Type 2 Diabetes? John Buse, MD, PhD Insulin Action in Muscle and Fat Promoting Glucose Uptake Amira Klip, PhD Defining the Underlying Defect in Insulin Action in Diabetes C. Ronald Kahn Insulin Action in the Kidney Richard Coward The Future of Smart Insulin Delivery Michael A. Weiss Read the Abstract Realizing the Promise of Stem Cell Therapy Douglas Melton, PhD Read the Abstract Molecular Insights Into Islet Autoimmunity Alice Long, PhD Preventing Type 1 Diabetes Carla J. Greenbaum, MD Load More Insulin and Beyond in the Hospitalized Patient Guillermo E. Umpierrez, MD, CDE Global Challenges in the Insulin Supply Change Jean Claude Mbanya, MD, PhD, FRCP Read the Abstract Barriers to Insulin Use in Adults Irl B. Hirsch, MD, MACP Cellular Consequences of Hypoglycemia Rory McCrimmon, MBChB, MD Minimizing Hypoglycemia in the Real World Chantal Mathieu, MD, PhD Read the Abstract Clinical Consequences of Hypoglycemia Stephanie Amiel, BSc, MBBS, MD, FRCP Read the Abstract The Eli Lilly Insulin Story Ruth E. Gimeno, PhD The Novo Nordisk Insulin Story Peter Kurtzhals, PhD Historical context at the University of Toronto Bernard Zinman Read the Abstract